β-防御素及Toll样受体参与分泌性中耳炎发病的体内研究
本文选题:β-防御素 + 分泌性中耳炎 ; 参考:《复旦大学》2010年硕士论文
【摘要】: 第一部分β-防御素在分泌性中耳炎大鼠咽鼓管鼓室的表达 目的 检测rBD-1、rBD-2 mRNA在分泌性中耳炎大鼠咽鼓管鼓室粘膜中的表达,初步探讨β-防御素在分泌性中耳炎发病机制中的作用。 方法 排除中耳感染的清洁级SD大鼠48只,随机分为4组,每组12只。前3组36只行颈部切口经右侧听泡注入脂多糖溶液(lmg/ml)30μL,造模后分别于1、3、7天断头取咽鼓管鼓室粘膜;对照组12只大鼠右侧听泡注入生理盐水30μL,左侧听泡作为空白对照组,与造模3天组同时取咽鼓管鼓室粘膜。 逆转录聚合酶链反应(RT-PCR)法检测咽鼓管鼓室粘膜rBD-1、rBD-2在mRNA水平的表达,Image J软件分析电泳图并进行半定量。 结果 正常SD大鼠咽鼓管鼓室粘膜存在rBD-1、rBD-2 mRNA的表达,rBD-1 mRNA的相对表达量较rBD-2 mRNA强(P0.01)。造模后1、3、7天,rBD-1 mRNA表达变化不明显,rBD-2 mRNA表达在造模后1、3天增加明显(P0.01),第7天渐回复到正常水平。 结论 在SD大鼠,rBD-1可能参与正常咽鼓管鼓室的防御功能,造模后rBD-2的表达增加可能与病原体入侵后的清除相关。 第二部分TLR-2、TLR-4在分泌性中耳炎小鼠咽鼓管鼓室的表达 目的 用PAF诱导BALB/c小鼠分泌性中耳炎模型,检测造模前后TLR-2、TLR-4在咽鼓管鼓室粘膜的表达,探讨PAF、TLR与分泌性中耳炎发病之间的关系。 方法 SPF级BALB/c小鼠50只,排除中耳感染,随机分为5组,每组10只。前4组经双侧鼓膜注入PAF 5μL(1μg)制作分泌性中耳炎小鼠模型,造模组8只小鼠分别于1、3、7、10天断头取咽鼓管鼓室粘膜;对照组8只小鼠右侧听泡注入生理盐水5μL,左侧听泡作为正常对照组,与造模7天组同时取咽鼓管鼓室粘膜。每组另2只小鼠取听泡固定并脱钙后制作冰冻切片,行HE染色观察造模后组织学变化。逆转录聚合酶链反应(RT-PCR),蛋白质印迹(western-blot)检测小鼠咽鼓管鼓室粘膜TLR-2、TLR-4的表达;免疫荧光(冰冻切片)确认TLR-2、TLR-4表达的具体部位。 结果 PAF 1μg经鼓膜注射诱导的BALB/c小鼠分泌性中耳炎,炎症可持续10天。正常BALB/c小鼠咽鼓管鼓室粘膜存在TLR-2、TLR-4 mRNA的表达,两者相对表达量比较差异不显著;PAF诱导后两者表达均增强,造模前后的表达差异有显著性(P0.01);western-blot证实炎症粘膜中TLR-2、TLR-4在蛋白水平的表达高于正常粘膜(P0.01);免疫荧光显示TLR-2、TLR-4广泛表达于鼓室粘膜,在炎症鼓室粘膜中表达有增强(P0.01),咽鼓管粘膜中主要为TLR-2绿色荧光,鼓膜及中耳腔炎症细胞表面主要为TLR-4红色荧光。 结论 PAF在中耳粘膜诱导TLR-2、TLR-4表达上调,PAF诱导的分泌性中耳炎小鼠模型可用以进一步研究PAF、TLR在分泌性中耳炎发病中的具体作用及相互联系。
[Abstract]:Part I expression of 尾 -defensin in eustachian tympanum of rats with secretory otitis media Purpose To investigate the role of 尾 -defensin in the pathogenesis of secretory otitis media by detecting the expression of rBD-1rBD-2 mRNA in the tympanic mucosa of eustachian tube in rats with secretory otitis media. Method Forty-eight clean SD rats excluding middle ear infection were randomly divided into 4 groups with 12 rats in each group. In the first three groups, 36 rats were injected with lipopolysaccharide (LPS) solution through right auditory bubble through the neck incision, and 30 渭 L of lipopolysaccharide solution was injected into the right auditory bubble. The mucosa of eustachian tube tympanum was cut off at 1, 3 and 7 days after modeling, while the right auditory bubble of 12 rats in the control group was injected with normal saline 30 渭 L, and the left auditory bubble was taken as the blank control group. The mucosa of tympanic cavity of eustachian tube was taken at the same time as the model group for 3 days. Reverse transcriptase polymerase chain reaction (RT-PCR) was used to detect the expression of rBD-1 and rBD-2 in eustachian tube tympanic mucosa at mRNA level. Result The expression of rBD-1rBD-2 mRNA in eustachian tube tympanic mucosa of SD rats was stronger than that of rBD-2 mRNA. The expression of rBD-1 mRNA did not change significantly on the 7th day after modeling. The expression of rBD-2 mRNA increased significantly on the 1st and 3rd day after modeling, and gradually returned to the normal level on the 7th day. Conclusion In SD rats, rBD-1 may be involved in the defense function of normal eustachian tube tympanum, and the increased expression of rBD-2 after modeling may be related to the clearance of pathogens after invasion. Part II expression of TLR-2TLR-4 in eustachian tube tympanum of mice with secretory otitis media Purpose A model of secretory otitis media in BALB/c mice induced by PAF was used to detect the expression of TLR-2 and TLR-4 in the tympanic mucosa of eustachian tube before and after the establishment of the model, and to explore the relationship between the expression of TLR-4 and the pathogenesis of secretory otitis media. Method SPF grade BALB/c mice were randomly divided into 5 groups with 10 rats in each group. The model of secretory otitis media was established in the first four groups by injecting PAF 5 渭 L 1 渭 g through bilateral tympanic membrane. The mucous membrane of the tympanic cavity of the eustachian tube was taken from 8 mice in the model group after 10 days. 8 mice in the control group were injected with normal saline 5 渭 L on the right side, and the mucosa of the tympanic cavity of the eustachian tube was taken from the left auditory bubble as the control group and the model group for 7 days. The other 2 mice in each group were fixed with auditory vesicles and decalcified to make frozen sections. The histological changes were observed by HE staining. Reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot (Western blot) were used to detect the expression of TLR-2 and TLR-4 in mouse eustachian tube tympanic mucosa, and the specific site of TLR-2TLR-4 expression was confirmed by immunofluorescence (frozen section). Result PAF 1 渭 g was injected into tympanic membrane to induce secretory otitis media in BALB/c mice. The inflammation lasted for 10 days. The expression of TLR-2 and TLR-4 mRNA in eustachian tympanic mucosa of normal BALB/c mice was not significantly different. The expression of TLR-2 and TLR-4 in inflammatory mucosa was higher than that in normal mucosa (P 0.01), and immunofluorescence showed that TLR-2 and TLR-4 were widely expressed in tympanic mucosa. In the mucosa of the inflammatory tympanum, the expression of P0.01G was enhanced, the green fluorescence of TLR-2 was mainly found in the mucosa of eustachian tube, and the TLR-4 red fluorescence was mainly found on the surface of the tympanic membrane and middle ear cavity. Conclusion The mouse model of secretory otitis media induced by PAF up-regulated the expression of TLR-2 and TLR-4 in middle ear mucosa could be used to further study the specific role and relationship of PAF-TLR in the pathogenesis of secretory otitis media.
【学位授予单位】:复旦大学
【学位级别】:硕士
【学位授予年份】:2010
【分类号】:R764
【相似文献】
相关期刊论文 前10条
1 徐光达;辛玉芬;金宏林;刘峰;于华;;分泌性中耳炎临床分析报道[J];中国医药指南;2011年16期
2 彭颖芳;;心理干预对分泌性中耳炎患者的影响[J];当代护士(综合版);2011年08期
3 刘光华;;鼓膜双穿孔灌注冲洗治疗分泌性中耳炎[J];实用医学杂志;2011年16期
4 李莹;李君梅;谢仕津;黎万荣;;白细胞介素-8与分泌性中耳炎[J];西南军医;2011年04期
5 汪光明;段凌云;;鼓膜二孔穿刺灌药治疗分泌性中耳炎的临床探讨[J];武汉大学学报(医学版);2011年04期
6 杨光;;儿童分泌性中耳炎与腺样体肥大的相关性研究[J];吉林医学;2011年26期
7 赵彩红;;单纯西医治疗效果不佳的分泌性中耳炎治疗[J];中国伤残医学;2011年06期
8 付发祥;宋蕾;;变态反应在分泌性中耳炎中的作用[J];实用医院临床杂志;2011年05期
9 徐恩明;徐忠强;王智楠;吴展元;;鼻内镜下等离子刀切除腺样体对儿童分泌性中耳炎转归的影响[J];听力学及言语疾病杂志;2011年04期
10 税磊;;耳内镜下鼓膜置管术治疗分泌性中耳炎的疗效观察[J];实用心脑肺血管病杂志;2011年10期
相关会议论文 前10条
1 何利勇;刘闻通;曾昭华;姚敏;周明辉;;以分泌性中耳炎为首发表现的软腭鳞癌1例[A];第十次全国中西医结合耳鼻咽喉科学术会议论文汇编[C];2010年
2 沈翠干;;中西医结合治疗分泌性中耳炎临床体会(摘要)[A];中医耳鼻喉学术传承与研究论文汇编[C];2009年
3 沈翠干;;中西医结合治疗分泌性中耳炎临床体会(摘要)[A];第15届全国中医耳鼻喉科学术研讨和继续教育年会论文汇编[C];2009年
4 郑沙盟;丛晶;;分泌性中耳炎的中西医结合治疗对策(摘要)[A];第三届第二次全国中西医结合耳鼻咽喉科学术大会论文汇编[C];2000年
5 胡大江;王建梅;;中西医结合治疗分泌性中耳炎43例[A];中西医结合“四种耳病”学术会汇编[C];2001年
6 叶果;;分泌性中耳炎临床治疗疗效观察(187例)[A];中华医学会全国中耳炎专题学术会议论文汇编[C];2004年
7 周国文;;成人腺样体肥大并发分泌性中耳炎11例临床分析[A];华东六省一市耳鼻咽喉-头颈外科学术会议暨2008年浙江省耳鼻咽喉-头颈外科学术年会论文汇编[C];2008年
8 唐云青;杨晓惠;;分泌性中耳炎与变态反应[A];中华医学会全国中耳炎专题学术会议论文汇编[C];2004年
9 陈娟;;放射性分泌性中耳炎[A];华东六省一市耳鼻咽喉-头颈外科学术会议暨2008年浙江省耳鼻咽喉-头颈外科学术年会论文汇编[C];2008年
10 张莉;刘永革;;腺样体切除术治疗儿童复发性分泌性中耳炎临床观察[A];全国中西医结合耳鼻咽喉科学术会论文汇编[C];2004年
相关重要报纸文章 前10条
1 沈阳市儿童医院 张新利;小儿分泌性中耳炎[N];卫生与生活报;2009年
2 北京同仁医院耳鼻咽喉头颈外科 夏寅;分泌性中耳炎是细菌感染[N];健康时报;2010年
3 李平;分泌性中耳炎的治疗[N];农村医药报(汉);2008年
4 吕斌;儿童应定期检查听力[N];中国中医药报;2009年
5 倪明;孩子何以“置若罔闻”[N];江苏科技报;2000年
6 卫新;吸鼻涕吸出中耳炎[N];江苏科技报;2003年
7 殷团芳;耳聋种种[N];健康报;2002年
8 为民;中耳炎何时做手术[N];保健时报;2004年
9 首都医科大学附属北京安贞医院耳鼻咽喉科 李希平;腺样体肥大未必要手术[N];保健时报;2010年
10 本报记者 黄静;过敏性鼻炎:不可忍字当先[N];人民政协报;2010年
相关博士学位论文 前2条
1 刘建治;变态反应相关分泌性中耳炎大鼠模型的建立及其机制研究[D];华中科技大学;2007年
2 付涛;TLR4信号通路及细胞外基质重塑与分泌性中耳炎的相关性研究[D];吉林大学;2007年
相关硕士学位论文 前10条
1 樊春笋;β-防御素及Toll样受体参与分泌性中耳炎发病的体内研究[D];复旦大学;2010年
2 阮玉珊;分泌性中耳炎中医及中西医结合随机对照治疗性文献评价[D];广州中医药大学;2010年
3 崔昕燕;糖皮质激素对分泌性中耳炎模型水通道蛋白1表达的调控[D];南京医科大学;2011年
4 宋红毛;微型通气管置管治疗分泌性中耳炎疗效分析[D];苏州大学;2012年
5 程景炜;龙胆泻肝丸干预防治放射性分泌性中耳炎的临床研究[D];南华大学;2012年
6 耿娟娟;IL-4和IL-13在分泌性中耳炎中对MUC5B的调节作用[D];遵义医学院;2011年
7 邝韶景;CO_2激光鼓膜造孔治疗分泌性中耳炎的研究[D];四川大学;2004年
8 郭江芳;参苓白术散加味治疗分泌性中耳炎的临床观察[D];黑龙江中医药大学;2009年
9 刘兴;健脾利水方治疗分泌性中耳炎脾虚痰浊证的临床疗效观察及咽鼓管表面活性物质研究[D];湖南中医药大学;2005年
10 王文娟;TLR4和IL-12在肥大腺样体中的表达及其在分泌性中耳炎中的意义[D];中南大学;2010年
,本文编号:1864541
本文链接:https://www.wllwen.com/yixuelunwen/yank/1864541.html